Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation
Abstract
Because oxygen-centered free radicals are involved in cell-mediated immune responses, we examined the possibility that these reactive species could also have a role in the lymphoproliferative response to alloantigens in the mixed lymphocyte culture (MLC). Three classes of agents that prevent the formation, or damaging effects, of oxygen radicals were tested: the non-permeant electron acceptor ferricyanide; the iron chelators desferrioxamine, desferrithiocin, octanohydroxamic acid, and pyridoxal isonicotinoyl hydrazone, which are thought to be capable of preventing the iron-catalyzed reduction of H2O2 to more reactive species; and the lipid-soluble free radical scavenger butylated hydroxyanisole. These compounds inhibited the proliferation of all potential responder cells in the MLC in a dose-dependent manner. Inhibition was observed only if these agents were present early (less than 40 hr) in the MLC; if added later, their effects were significantly reduced. In contrast, the interleukin 2 (IL 2)-dependent proliferation of CTLL-2 cells or Con A blasts was not affected by these compounds at concentrations that inhibited proliferation in MLC by greater than 90%. Interleukin 1 (IL 1) production by peritoneal exudate cells and IL 2 and IL 1 levels in MLC were not affected by any of the agents tested. By flow microfluorometry, the expression of IL 2 receptors on stimulated T cells was found to be inhibited in the presence of these drugs. Taken together, the data point to an important role for free radical-mediated processes during the early stages of T lymphocyte activation, before IL 2 receptor expression.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ROS can play critical roles in shaping T cell responses.
“There has long been evidence that ROS can play critical roles in shaping T cell responses (28–30).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [28]
Cited by
Sorted by citations
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · see citing works
“Initial evidence for redox signaling in this process stemmed from the observations that treatment of primary T cells with pharmacological antioxidants inhibited proliferation and production of the cytokine interleukin-2 (IL-2) following T-cell receptor stimulation in vitro [91].”
BackgroundPhysiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632 · see citing works
Oxygen radicals and human disease
CROSS, C. E., HALLIWELL, B., BORISH, E. T., PRYOR, W. A., AMES, B. N., SAUL, R. L., McCORD, J. M., & HARMAN, D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-526 · Cited by 1,856 · see citing works
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363 · see citing works
The Regulation of Reactive Oxygen Species Production during Programmed Cell Death
Tan, S., Sagara, Y., Liu, Y., Maher, P. A., & Schubert, D. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.6.1423 · Cited by 730 · see citing works
“Previous work suggests that ROS can act as signals in apoptotic cell death (Chaudhri et al., 1986, 1988; Nakamura et al., 1993; Staal et al., 1994; Russo et al., 1995; Slater et al., 1995; Kazzaz et al., 1996; Abe et al., 1997; Esposito et al., 1997; Goldstone and Hunt, 1997).”
BackgroundOxidative stress during viral infection: A review
Schwarz, K. B. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)00131-1 · Cited by 652 · see citing works
Induction of reactive oxygen species: an emerging approach for cancer therapy
Zou, Z., Chang, H., Li, H., & Wang, S. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1424-9 · Cited by 586 · see citing works
“In addition, treatment of primary T cells and mice with antioxidants reduces T cell proliferation and production of IL-2, suggesting that ROS is required during initial stages of T cell activation [106, 107].”
BackgroundReactive Oxygen Species in the Immune System
Yang, Y., Bazhin, A. V., Werner, J., & Karakhanova, S. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2012.755176 · Cited by 508 · see citing works
Functions of glutathione and glutathione disulfide in immunology and immunopathology
Dröge, W., Schulze‐Osthoff, K., Mihm, S., Galter, D., Schenk, H., Eck, H., Roth, S., & Gmünder, H. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.14.7958618 · Cited by 444 · see citing works
Mitochondrial ROS regulation of proliferating cells
Diebold, L., & Chandel, N. S. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.198 · Cited by 391 · see citing works
“ROS were first implicated in T-cell function in the mid-1980s when it was found that the treatment of primary T-cells with antioxidants inhibits both proliferation and IL-2 production [98].”
BackgroundDypbukt, J. M., Ankarcrona, M., Burkitt, M. J., Sjöholm, Å., Ström, K., Orrenius, S., & Nicotera, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43849-5 · Cited by 361 · see citing works
Revving the Engine: Signal Transduction Fuels T Cell Activation
Jones, R. G., & Thompson, C. B. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.008 · Cited by 349 · see citing works
“Although ROS is toxic in many biological settings, there is evidence that its generation may play a critical role in shaping the T cell response (Chaudhri et al., 1986), potentially by stimulating nucleotide biosynthesis and S phase entry.”
BackgroundYang, Z., Day, Y., Toufektsian, M.-C., Xu, Y., Ramos, S. I., Marshall, M. A., French, B. A., & Linden, J. M. (2006) · Circulation · doi:10.1161/circulationaha.106.649244 · Cited by 286 · see citing works
Autophagy Signaling Through Reactive Oxygen Species
Huang, J., Lam, G. Y., & Brumell, J. H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3554 · Cited by 226 · see citing works
“ROS also modulate T-cell proliferation and apoptosis (17, 43, 52) and are therefore critical for maintaining T-cell homeostasis.”
Verhasselt, V., Berghe, W. V., Vanderheyde, N., Willems, F., Haegeman, G., & Goldman, M. (1999) · PubMed · Cited by 211 · see citing works
Sandstrom, P. A., Tebbey, P. W., Cleave, S. V., & Buttke, T. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42178-8 · Cited by 205 · see citing works
Free Radicals and the Regulation of Mammalian Cell Proliferation
Burdo, R. H., & Rice-Evans, C. A. (1989) · Free Radical Research Communications · doi:10.3109/10715768909087918 · Cited by 191 · see citing works
Sandstrom, P. A., & Buttke, T. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4708 · Cited by 186 · see citing works
Verhasselt, V., Berghe, W. V., Vanderheyde, N., Willems, F., Haegeman, G., & Goldman, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2569 · Cited by 185 · see citing works
Regulation of redox balance in cancer and T cells
Kong, H., & Chandel, N. S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000257 · Cited by 180 · see citing works
“This was first evidenced by an observation that primary T cells treated with antioxidants following TCR stimulation exhibit reduced interleukin (IL)-2 receptor expression and proliferation (80).”
BackgroundDNA damage-induced gene expression: Signal transduction and relation to growth factor signaling
Herrlich, P. A., Ponta, H., & Rahmsdorf, H. J. (1992) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/3540551921_7 · Cited by 180 · see citing works
Yang, C., Wu, S., Mou, Z., Zhou, Q., Dai, X., Ou, Y., Chen, X., Chen, Y., Xu, C., Hu, Y., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.022 · Cited by 178 · see citing works
The Role of Oxidative Stress in the Pathogenesis of Asthma
Cho, Y. S., & Moon, H. (2010) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2010.2.3.183 · Cited by 175 · see citing works
T Cell Receptor Stimulation, Reactive Oxygen Species, and Cell Signaling
Williams, M. S., & Kwon, J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.05.029 · Cited by 167 · see citing works
Tardieu, M., Héry, C., Peudenier, S., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320104 · Cited by 160 · see citing works
Oxidative Stress and Redox Modulation Potential in Type 1 Diabetes
Delmastro-Greenwood, M. M., & Piganelli, J. D. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/593863 · Cited by 129 · see citing works
“supported our experimentation by demonstrating attenuation of Tcell proliferation and IL-2R expression following antioxidant treatment [186, 187].”
BackgroundCell proliferation, cell death and aging
Franceschi, C. (1989) · Aging Clinical and Experimental Research · doi:10.1007/bf03323871 · Cited by 128 · see citing works
The Requirement of Reversible Cysteine Sulfenic Acid Formation for T Cell Activation and Function
Michalek, R. D., Nelson, K. J., Holbrook, B. C., Yi, J. S., Stridiron, D., Daniel, L. W., Fetrow, J. S., King, S. B., Poole, L. B., & Grayson, J. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6456 · Cited by 112 · see citing works
“An essential role for ROI in T cell function was initially demonstrated by reports indicating that antioxidants inhibit proliferation and IL-2 production when administered during the early stages of T cell activation (17, 18).”
BackgroundJones, R. G., Bui, T., White, C., Madesh, M., Krawczyk, C. M., Lindsten, T., Hawkins, B. J., Kubek, S., Frauwirth, K. A., Wang, Y. L., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.023 · Cited by 109 · see citing works
“What is the importance of Ca-dependent ROS generation for T cell activation? Experiments conducted with ROS scavengers have suggested that ROS may be required for T cell proliferation (Chaudhri et al., 1986).”
Surface thiols of human lymphocytes and their changes after in vitro and in vivo activation
Lawrence, D. A., Song, R., & Webert, P. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.5.611 · Cited by 102 · see citing works
The complex interplay between autophagy, apoptosis, and necrotic signals promotes T‐cell homeostasis
Walsh, C. M., & Edinger, A. L. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00919.x · Cited by 99 · see citing works
Chaudhri, G., Hunt, N. H., Clark, I. A., et al. (1988) · Cellular Immunology · doi:10.1016/0008-8749(88)90174-8 · Cited by 97 · see citing works
Self-citationThe role of adhesion molecules and T cells in ischemic renal injury
Burne-Taney, M. J., & Rabb, H. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200301000-00014 · Cited by 93 · see citing works
Clinical significance of T cell metabolic reprogramming in cancer
Herbel, C., Patsoukis, N., Bardhan, K., Seth, P., Weaver, J. D., & Boussiotis, V. A. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0110-9 · Cited by 93 · see citing works
In vivo T Cell Activation in Lymphoid Tissues is Inhibited in the Oxygen-Poor Microenvironment
Ohta, A., Diwanji, R., Kini, R., Subramanian, M., Ohta, A., & Sitkovsky, M. V. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00027 · Cited by 86 · see citing works
“Treatment of T cells with Co2+ or desferrioxamine, which are often used to mimic hypoxia, also reduced T cell activation (Lederman et al., 1984; Carotenuto et al., 1986; Chaudhri et al., 1986; Wang et al., 1996; Pae et al., 2004).”
BackgroundRegulation of T-cell apoptosis by reactive oxygen species
Hildeman, D. A. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.03.023 · Cited by 88 · see citing works
Activated lymphocytes as a metabolic model for carcinogenesis
Macintyre, A. N., & Rathmell, J. C. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-5 · Cited by 87 · see citing works
“While some degree of ROS is beneficial for both T cell activation [55] and tumor development [56], excessive ROS leads to oxidative organelle”
BackgroundA common mitochondrial haplogroup is associated with elevated total serum IgE levels
Raby, B. A., Klanderman, B. J., Murphy, A., Mazza, S., Camargo, C. A., Silverman, E. K., & Weiss, S. T. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.05.029 · Cited by 83 · see citing works
The generation of oxygen radicals: A positive signal for lymphocyte activation
Fidelus, R. K. (1988) · Cellular Immunology · doi:10.1016/0008-8749(88)90015-9 · Cited by 79 · see citing works
A new lease of life for an old enzyme
Martini, G., & Ursini, M. V. (1996) · BioEssays · doi:10.1002/bies.950180806 · Cited by 79 · see citing works
Redox Signaling, Neuroinflammation, and Neurodegeneration
Aguilera, G., Colín-González, A. L., Rangel‐López, E., Chavarría, A., & Santamarı́a, A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7099 · Cited by 79 · see citing works
“…culture, iron chelators and a lipid-soluble free radical scavenger prevented the iron-catalyzed reduction of H 2 O 2 to OH, and they inhibited the cellular proliferation, demonstrating that ROS are positive mediators during early stages of T lymphocyte activation and proliferation (28, 29).”
O’Donnell, V. B., & Azzi, A. (1996) · Biochemical Journal · doi:10.1042/bj3180805 · Cited by 74 · see citing works
Wang, J., Jerrells, T. R., & Spitzer, J. J. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02085-3 · Cited by 75 · see citing works
Kamiński, M. M., Röth, D., Krammer, P. H., & Gülow, K. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0235-0 · Cited by 72 · see citing works
Hydrogen peroxide is involved in lymphocyte activation mechanisms to induce angiogenesis
Monte, M., Davel, L., & de Lustig, E. S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00506-0 · Cited by 71 · see citing works
Preterm premature rupture of the membranes and antioxidants: the free radical connection
Wall, P. D., Pressman, E. K., & Woods, J. R. (2002) · Journal of Perinatal Medicine · doi:10.1515/jpm.2002.071 · Cited by 68 · see citing works
Jayle, C., Favreau, F. D., Zhang, K., et al. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00338.2006 · Cited by 65 · see citing works
Dornand, J., & Gerber, M. (1989) · PubMed · Cited by 62 · see citing works
Iwanaga, K., Hasegawa, T., Hultquist, D. E., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000256283.06469.d4 · Cited by 61 · see citing works
“Previous reports showed that melatonin, which has been identified as an effective antioxidant and scavenger of free radicals, prolongs cardiac allograft survival in rats (28) and antioxidants and hydroxyl radical scavengers have been used to inhibit T-cell proliferation and interleukin-2 receptor expression on stimula…”
BackgroundRedox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation
Goldstone, S. D., & Hunt, N. H. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(96)00150-4 · Cited by 60 · see citing works
Self-citationRenton, F. J., & Jeitner, T. M. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00099-8 · Cited by 57 · see citing works
Transcription factors as targets for oxidative signalling during lymphocyte activation
Goldstone, S. D., Fragonas, J., Jeitner, T. M., et al. (1995) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(95)00088-x · Cited by 57 · see citing works
Self-citationLaniewski, N. G., & Grayson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11246-11257.2004 · Cited by 55 · see citing works
“These data are consistent with earlier data from in vitro experiments using antioxidants, such as radical scavengers, iron chelators, and aminothiols, which blocked the proliferation of T cells induced by alloantigen (7).”
ResultAntioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice.
Thumwood, C. M., Hunt, N. H., Cowden, W. B., & Clark, I. A. (1989) · PubMed Central · Cited by 56 · see citing works
Self-citationRedox regulation of T-cell receptor signaling
Simeoni, L., & Bogeski, I. (2015) · Biological Chemistry · doi:10.1515/hsz-2014-0312 · Cited by 52 · see citing works
Cayota, A., Vuillier, F., Gonzalez, G. A., & Dighiero, G. (1996) · Blood · doi:10.1182/blood.v87.11.4746.bloodjournal87114746 · Cited by 49 · see citing works
Maly, F. E. (1990) · Free Radical Research Communications · doi:10.3109/10715769009087987 · Cited by 46 · see citing works
The intracellular oxidation of 2′,7′-dichlorofluorescin in murine T lymphocytes
van Reyk, D. M., King, N. J. C., Dinauer, M. C., & Hunt, N. H. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00449-4 · Cited by 45 · see citing works
Self-citationThe role of metabolic reprogramming in T cell fate and function.
Patsoukis, N., Bardhan, K., Weaver, J. D., Herbel, C., Seth, P., Li, L., & Boussiotis, V. A. (2016) · PubMed · Cited by 41 · see citing works
Melatonin in vivo prolongs cardiac allograft survival in rats
Jung, F. J., Yang, L., Härter, L., et al. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00133.x · Cited by 42 · see citing works
“Antioxidants and hydroxyl radical scavengers have been used to inhibit T cell proliferation and IL-2 receptor expression on stimulated T cells in vitro [24, 25].”
BackgroundKrammer, P. H., Kamiński, M. M., Kießling, M. K., & Gülow, K. (2007) · Advances in cancer research · doi:10.1016/s0065-230x(06)97005-5 · Cited by 42 · see citing works
Pieri, C., Recchioni, R., & Moroni, F. (1993) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(93)90048-v · Cited by 39 · see citing works
Increased oxidative metabolism in PMA-activated lymphocytes: A flow cytometric study
Rabesandratana, H., Fournier, A.-M., Château, M., et al. (1992) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(92)90089-4 · Cited by 39 · see citing works
Reeve, V. E., Bosnic, M., & Rozinova, E. (1993) · PubMed · Cited by 39 · see citing works
Lynch, F., Chaudhri, G., Allan, J. E., et al. (1987) · European Journal of Immunology · doi:10.1002/eji.1830170123 · Cited by 37 · see citing works
Self-citationHolmes, K. T., Lean, C. L., Hunt, N. H., & King, N. J. C. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910160102 · Cited by 36 · see citing works
Self-citationRao, P. N., Walsh, T. R., Makowka, L., et al. (1990) · Transplantation · doi:10.1097/00007890-199006000-00006 · Cited by 33 · see citing works
Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine.
Polson, R. J., Jenkins, R., Lombard, M. C., et al. (1990) · PubMed · Cited by 33 · see citing works
Mechanisms regulating immune surveillance of cellular stress in cancer
Seelige, R., Searles, S. C., & Bui, J. D. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2597-7 · Cited by 31 · see citing works
“In line with that, antioxidants directly inhibit T-cell activation, proliferation and IL-2 receptor expression [24, 25, 123].”
BackgroundOxidative signalling and gene expression during lymphocyte activation
Goldstone, S. D., Milligan, A., & Hunt, N. H. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(96)00082-1 · Cited by 31 · see citing works
Self-citationPack, R. A., Hardy, K., Madigan, M. C., & Hunt, N. H. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(01)00110-9 · Cited by 30 · see citing works
Self-citationAmelioration of murine cerebral malaria by dietary restriction
Hunt, N. H., Manduci, N., & Thumwood, C. M. (1993) · Parasitology · doi:10.1017/s0031182000068049 · Cited by 29 · see citing works
Self-citationClark, R., Brannen, K., Sanders, J. E., & Hoberman, A. (2011) · Birth defects research. Part B. Developmental and reproductice toxicology · doi:10.1002/bdrb.20282 · Cited by 27 · see citing works
In vivo immunoregulatory properties of the novel mitochondria-targeted antioxidant SkQ1
Yang, Y., Karakhanova, S., Soltek, S., Werner, J., Philippov, P. P., & Bazhin, A. V. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.04.010 · Cited by 27 · see citing works
Role of oxidant injury on macrophage lipoprotein lipase (LPL) production and sensitivity to LPL
Renier, G., Desfaits, A.-C., Lambert, A., et al. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37578-7 · Cited by 27 · see citing works
Hunt, N. H., Cook, E. P., & Fragonas, J. (1991) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(91)90056-d · Cited by 26 · see citing works
Self-citationThe nexus between redox state and intermediary metabolism
Zoccarato, A., Nabeebaccus, A., Oexner, R. R., Santos, C. X. C., & Shah, A. M. (2021) · FEBS Journal · doi:10.1111/febs.16191 · Cited by 27 · see citing works
Aillet, F., Gougerot‐Pocidalo, M., Virelizier, J., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.405 · Cited by 25 · see citing works
Sullivan, P. J., Sweeney, K. J., Hirpara, K. M., et al. (2009) · British journal of surgery · doi:10.1002/bjs.6554 · Cited by 23 · see citing works
Willenborg, D. O., Bowern, N. A., Danta, G., & Doherty, P. C. (1988) · Journal of Neuroimmunology · doi:10.1016/0165-5728(88)90020-3 · Cited by 23 · see citing works
Fedyk, E. R., & Phipps, R. P. (1994) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(94)90105-8 · Cited by 23 · see citing works
Hancock, J. T., HENDERSON, L. M., & Jones, O. (1990) · PubMed · Cited by 23 · see citing works
Effects of anti-oxidants on ornithine decar☐ylase in mitogenically-activated T lymphocytes
Hunt, N. H., & Fragonas, J. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(92)90046-e · Cited by 22 · see citing works
Self-citationBénichou, G., Kanellopoulos, J., Mitenne, F., et al. (1989) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1989.tb01210.x · Cited by 21 · see citing works
Pellom, S. T., Michalek, R. D., Crump, K. E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081134 · Cited by 19 · see citing works
“This increase is essential for activation as antioxidant treatment, which lowers ROI, decreases T cell activation [4].”
BackgroundOxidative stress and coxsackievirus infections as mediators of beta cell damage: a review.
Sharma, V., Kalim, S., Srivastava, M. K., Nanda, S., & Mishra, S. (2009) · Scientific Research and Essays · doi:10.5897/sre.9000707 · Cited by 18 · see citing works
Peroxiredoxin II Regulates Effector and Secondary Memory CD8<sup>+</sup>T Cell Responses
Michalek, R. D., Crump, K. E., Weant, A. E., Hiltbold, E. M., Juneau, D. G., Moon, E.-Y., Yu, D.-Y., Poole, L. B., & Grayson, J. M. (2012) · Journal of Virology · doi:10.1128/jvi.01559-12 · Cited by 17 · see citing works
“These changes are critical because antioxidant treatment, which lowers ROI, decreases activation and proliferation (9).”
BackgroundROS-Responsive Biomaterial Design for Medical Applications
Lee, J. B., Shin, Y. M., Kim, W. S., Kim, S. Y., & Sung, H. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0445-3_15 · Cited by 18 · see citing works
Kwak, Y. (2006) · Journal of Sports Sciences · doi:10.1080/02640410500386233 · Cited by 17 · see citing works
Oxygen radical production by transformed B lymphocytes
Jones, O., Hancock, J. T., & HENDERSON, L. M. (1991) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(91)90004-6 · Cited by 17 · see citing works
Benke, P. J., Levcovitz, H., Paupe, J., & Tozman, E. (1990) · Metabolism · doi:10.1016/0026-0495(90)90184-e · Cited by 17 · see citing works
van Reyk, D. M., Sarel, S., & Hunt, N. H. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00347-6 · Cited by 16 · see citing works
Self-citationvan Reyk, D. M., Sarel, S., & Hunt, N. H. (1992) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(92)90092-y · Cited by 16 · see citing works
Self-citationEffect of orally active hydroxypyridinone iron chelators on human lymphocyte function
Pattanapanyasat, K., Webster, H. K., Tongtawe, P., et al. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb04587.x · Cited by 16 · see citing works
“This differs from previous work showing that DF inhibited the process of T-cell activation either by directly inhibiting expression of IL-2 receptors (Carotenuto et al, 1986) or by suppressing the generation of hydroxyl radical formation essential to IL-2 receptor expression (Chaudhri et al. 1986).”
Nottet, H. S. L. M., van Asbeck, B. S., de Graaf, L., Vos, N., Visser, M. R., & Verhoef, J. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.6.702 · Cited by 15 · see citing works
“Hydroxyl radicals reduce the activity of membraneassociated tumor necrosis factor a (TNF-a) receptors on monocytes [37, 38] and induce the expression of interleukin-2 (IL-2) receptors on stimulated T cells [39].”
BackgroundPhysiological Functions of Mitochondrial Reactive Oxygen Species
Choi, T. G., & Kim, S. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88386 · Cited by 15 · see citing works
Redox Mechanisms in T Cell Activation
Hunt, N. H., van Reyk, D. M., Fragonas, J., et al. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7424-3_21 · Cited by 14 · see citing works
Self-citationKeizer, E., Valdes, I. D., McCann, B. L., Bignell, E., Wösten, H. A. B., & de Cock, H. (2022) · mSphere · doi:10.1128/msphere.00874-21 · Cited by 12 · see citing works
Carbon Monoxide Inhibits T Cell Proliferation by Suppressing Reactive Oxygen Species Signaling
Yan, Y., Wang, L., Chen, S., Zhao, G., Fu, C., Xu, B., Tan, X., Xiang, Y., & Chen, G. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7814 · Cited by 13 · see citing works
“Furthermore, preventing intra-cellular ROS generation with antioxidants or by using T-Uqcrfs -/- mice with reduced mitochondrial ROS production in their T cells can significantly inhibit antigen-specific T cell activation and proliferation (8,46).”
Intracellular Cu/Zn superoxide dismutase levels in T and non-T cells from normal aged subjects
Grigolo, B., Borzı̀, R. M., Mariani, E., Monaco, M., Cattini, L., Porstmann, T., & Facchini, A. (1994) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(94)90035-3 · Cited by 12 · see citing works
- Authors
- Chaudhri, G., Clark, I. A., Hunt, N. H., Cowden, W. B., & Ceredig, R.
- Affiliations
- Australian National University (AU)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1986-10
- Volume
- 137
- Issue
- 8
- Pages
- 2646-2652
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1563909789
- Cited by
- 138
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 3 · 2021: 2 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 5 · 2012: 4
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- antioxidants, oxygen free radicals, T cell activation, alloantigen, lymphocyte proliferation, mixed lymphocyte reaction, ferricyanide, iron chelators, deferoxamine, pyridoxal isonicotinoyl hydrazone, butylated hydroxyanisole, interleukin-2 receptor, interleukin-1, interleukin-2, cell-mediated immunity
- MeSH terms
- Animals, Antioxidants, Female, Flow Cytometry, Interleukin-2, Isoantigens, Kinetics, Lymphocyte Culture Test, Mixed, Lymphocyte Activation, Mice, Inbred CBA, Mice, Inbred C3H, Mice, Inbred C57BL, Mice, Inbred DBA, T-Lymphocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review